Donor-derived circulating endothelial cells after kidney transplantation

Transplantation

Volumn 74, Issue 9, 2002, Pages 1320-1327

  Popa, Eliane R ^a   Kas Deelen, Adriana M ^a   Hepkema, Bouke G ^a   Van Son, Willem J ^a   Hauw The, T ^a   Harmsen, Martin C ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN;

ADULT; ALLELE; ARTICLE; CELL DAMAGE; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; ENDOTHELIUM CELL; FEMALE; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; KIDNEY ALLOGRAFT; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MALE; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; VASCULARIZATION;

EID: 0037112935     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200211150-00021     Document Type: Article

References (29)

1. Parvums DV. The pathology of ischemia-reperfusion. In: Grace PA, Mathie RT, eds. Ischemia Reperfusion Injury, London: Blackwell Science, 1999: 3.
2. Parmar MS, Kjellstrand CM, Solez K, et al. Glomerular endothelial cell detachment in paired cadaver kidney transplants: Evidence that some cadaver donors have pre-existing endothelial injury. Clin Transplant 1994; 8: 120.
3. Grefte JM, van der Giessen M, van Son W, et al. Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection. J Infect Dis 1993; 167: 270.
4. Percivalle E, Revello MG, Vago L, et al. Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement. J Clin Invest 1993; 92: 663.
5. Grefte JM, van der Giessen M, Blom N, The TH, et al. Circulating cytomegalovirus-infected endothelial cells after renal transplantation: Possible clue to pathophysiology? Transplant Proc 1995; 27: 939.
6. Sabate M, Manito N, Cequier A, et al. Acute rejection, cytomegalovirus infection and endothelial dysfunction early after heart transplantation. Transplant Proc 1995; 27: 2346.
7. Arbustini E, Morbini P, Grasso M, et al. Human cytomegalovirus early infection, acute rejection, and major histocompatibility class II expression in transplanted lung. Transplantation 1996; 61: 418.
8. Ryffel B, Foxwell BM, Gee A, et al. Cyclosporine-relationship of side-effects to mode of action. Transplantation 1988; 46(suppl 2): 90S.
9. Remuzzi G, Bertani T. Renal vascular and thrombotic effects of cyclosporine. Am J Kidney Dis 1989; 13: 261.
10. Tullius SG, Heemann U, Hancock WW, et al. Long-term kidney isografts develop functional and morphologic changes that mimic those of chronic allograft rejection. Ann Surg 1994; 220: 425.
11. Weight SC, Bell PR, Nicholson ML. Renal ischemia-reperfusion injury. Br J Surg 1996; 83: 162.
12. Kas-Deelen AM, de Maar EF, Harmsen MC, et al. Uninfected and cytomegalic endothelial cells in blood during cytomegalovirus infection: Effect of acute rejection. J Infect Dis 2000; 181: 721.
13. Kas-Deelen AM, Harmsen MC, de Maar EF, et al. Acute rejection before CMV infection enhances von Willebrand factor and sVCAM-1in blood. Kidney Int 2000; 56: 2532.
14. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411.
15. The TH, Harmsen MC, van der Bij W, et al. Relationship between monitoring the viral load in blood, human cytomegalovirus pathophysiology and management strategies of patients after transplantation. Monogr Virol 1998; 21: 262.
16. Verschuuren EA, Harmsen MC, Limburg PC, et al. Towards standardization of the human cytomegalovirus antigenemia assay. Intervirology 1999; 42: 382.
17. Pober JS, Gimbrone MA, Lapierre LA, et al. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol 1986; 137: 1893.
18. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225.
19. Pratschke J, Wilhelm MJ, Kusaka M, et al. Accelerated rejection of renal allografts from brain-dead donors. Ann Surg 2000; 232: 263.
20. Tilney NL. Chronic rejection and its risk factors. Transplant Proc 1999; 31(1-2A): 41S
21. Skalak R, Skalak TC. Flow behavior of leukocytes in small tubes. In: Granger DN, Schmid-Schonbein GW, eds. Physiology and Pathophysiology of Leukocyte Adhesion. New York, Oxford University Press 1995, p 97.
22. Schuger L, Varani J, Marks RM, et al. Cytotoxicity of tumor necrosis factor-alpha for human umbilical vein endothelial cells. Lab Invest 1989; 61: 62.
23. Meyrick B, Christman B, Jesmok G. Effects of recombinant tumor necrosis factor-alpha on cultured pulmonary artery and lung microvasculature endothelial monolayers. Am J Pathol 1991; 138: 93.
24. Campbell WN, Ding X, Goldblum SE. Interleukin-1 alpha and -beta augment pulmonary artery transendothelial albumin flux in vitro. Am J Physiol 1992; 263: L128.
25. Neary P, Redmont HP. Ischemia-reperfusion injury and the systemic inflammatory response syndrome. In: Grace PA, Mathie RT, eds. Ischemia-Reperfusion Injury. London, Blackwell Science 1999, p 123.
26. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964.
27. Takahashi T, Kalka C, Masuda H, et al. Ischemia- and cytokine-induced mobilization of bone-marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999; 5: 434.
28. Murohara T, Ikeda H, Duan J, et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000; 105: 1527.
29. Lagaaij EL, Cramer-Knijnenburg GF, van Kemenade FJ, et al. Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet 2001; 357: 33.